Thursday, 8 August 2019

Global Anticoagulants Market Top Scenario, SWOT Analysis, Business Overview & Forecasts 2018-2026

Researchmoz added Most up-to-date research on “Anticoagulants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026“ to its huge collection of research reports.
Anticoagulants Market – Overview
Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.
Get Free PDF for more Professional and Technical insights @
This report analyzes the current and future prospects of the global anticoagulants market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary researches. Detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market related factors such as technological developments, product innovation, and expansion of infrastructural facilities by major & small major products, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segments of the global anticoagulants market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Based on route of administration, the global anticoagulants market has been bifurcated into oral and injectables. In terms of drug class, the market has been classified into factor Xa inhibitors (NOAC/DOAC), heparins, direct thrombin inhibitors, and vitamin K antagonists. Based on indication, the global anticoagulants market has been categorized into deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation & heart attack, and others. In terms of distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies.
(*Fill the form and our sales representative will get back to you for assistance)
Key players operating in the global anticoagulants market include Bayer Healthcare, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Johnson & Johnson Services, Inc., and Sanofi.
The global anticoagulants market has been segmented as follows:
Global Anticoagulants Market, by Route of Administration
  • Oral
  • Injectables
Global Anticoagulants Market, by Drug Class
  • Factor XA Inhibitors (NOAC/DOAC)
  • Heparins
  • Direct Thrombin Inhibitors
  • Vitamin K Antagonists
Global Anticoagulants Market, by Indication
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Atrial Fibrillation & Heart Attack
  • Others
Global Anticoagulants Market, by Distribution channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
You can Purchase This Report from Here @
Global Anticoagulants Market, by Region
  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia & New Zealand, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (GCC Countries, South Africa, Rest of Middle East & Africa)
Contact Us:
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
Toll Free: 866-997-4948 (US-CANADA)
Follow us on LinkedIn @
Follow us on Blogger @

Labels: , ,


Post a Comment

Subscribe to Post Comments [Atom]

<< Home